EUVIMEDEUVIMED entdecken
Crossref

Subcutaneous hormone implants

Jennifer Tamblyn, Lynne Robinson, Eimear Maguire, Alice Hodge, Paula Briggs

Post Reproductive Health · 2023-12 · 29 (4) · 240-243

DOI: 10.1177/20533691231214870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Post Reproductive Health, online erschienen am 24.11.2023. Verfasst von Jennifer Tamblyn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Teaching Hospital Trust, Leeds, UK. Hauptthemen laut MEDLINE: Estradiol, Follicle Stimulating Hormone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HRT is widely available in oral and transdermal formulations. For most women, these provide the necessary delivery route options to achieve reasonable symptom control. Women with a body mass index greater than 30, are advised to use a transdermal delivery route, with a neutral impact on the risk of venous thromboembolism. However, some women fail to absorb hormonal therapy through the skin, for reasons which are poorly understood. This “ Tale ” , written on World Mental Health Day, is a collaboration from Leeds, Liverpool, and Birmingham. We describe the journeys of two patients from hysterectomy, to menopausal symptoms including mood related symptoms, suboptimal symptom control with standard HRT and fi nally to complete resolution of symptoms with HRT implants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EstradiolFollicle Stimulating HormoneHumansDrug Implants

Substanzen

EstradiolFollicle Stimulating HormoneDrug Implants

Autor:innen und Institutionen

  • Leeds Teaching Hospital Trust, Leeds, UK.
  • University of Birmingham, Birmingham, UK.
  • Birmingham Women's Hospital, Birmingham, UK.
  • Liverpool Women's Hospital, Liverpool, UK.
  • Intercalting MRES student, Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
  • Liverpool Women's NHS Foundation Trust, Liverpool, UK.

Zitieren

APA

Tamblyn, J., Robinson, L., Maguire, E., Hodge, A., & Briggs, P. (2023). Subcutaneous hormone implants. Post Reproductive Health, 29(4), 240-243. https://doi.org/10.1177/20533691231214870

Vancouver

Tamblyn J, Robinson L, Maguire E, Hodge A, Briggs P. Subcutaneous hormone implants. Post Reproductive Health. 2023;29(4):240-243. doi:10.1177/20533691231214870

BibTeX
@article{Tamblyn2023,
  author = {Tamblyn, Jennifer and Robinson, Lynne and Maguire, Eimear and Hodge, Alice and Briggs, Paula},
  title = {Subcutaneous hormone implants},
  journal = {Post Reproductive Health},
  year = {2023},
  volume = {29},
  number = {4},
  pages = {240--243},
  doi = {10.1177/20533691231214870}
}
Kostenlos starten →